Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Decision Support Techniques × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12 Colorectal Neoplasms 6 Prostatic Neoplasms 3 Neoplasms 3 Ovarian Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Melanoma 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Kidney Neoplasms 1 Heartburn 1 Healthy Volunteers 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Depression 1 Dementia 1 Colorectal Cancer Screening 1 COVID-19 1 Breast Carcinoma In Situ 1 Breast Cancer Screening 1 Behavior 1 Barrett Esophagus 1 Advanced Cancer 1

Interventions

Nivolumab 14 Surveys and Questionnaires 7 Ipilimumab 6 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2 Cisplatin 2 Chlorogenic Acid 2 Capecitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04606238 2023-01-10

PETUPAL

University Hospital Heidelberg

Phase NA Unknown

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡